Trexquant Investment’s Eli Lilly LLY Stock Holding History

Trexquant Investment’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$600K	Buy	+500	New	+$511K	﹤0.01%	1595

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Trexquant Investment's LLY Position: Q2 2026 in Review

Trexquant Investment increased its Eli Lilly (LLY) stake by 7% in Q2 2026, buying an estimated $6.05M and bringing the position to 90,850 shares worth $109M. The position accounts for 0.64% of the portfolio, ranked #14.

Trexquant Investment first reported a position in LLY in Q4 2014 and has held it in 23 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Trexquant Investment held 90,850 shares of Eli Lilly worth $109M as of Q2 2026.
Trexquant Investment bought 5,924 Eli Lilly shares in Q2 2026, an estimated $6.05M.
Eli Lilly made up 0.64% of Trexquant Investment's portfolio in Q2 2026, its #14 holding.
Trexquant Investment first reported a position in Eli Lilly in Q4 2014 and has held it in 23 quarters since.
4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.